Sort
10,829 grants matching “car t”
The Use of Blood Cells and Optical Cerebral Complex IV Redox States in a Porcine Model of CO Poisoning with Evaluation of Mitochondrial Therapy
$709,760David H Jang · University Of Pennsylvania · R01 · FY2023 · HL
Targeting CD83 to reduce leukemia relapse and GVHD after allogeneichematopoietic cell transplantation
$709,029Brian C Betts · Roswell Park Cancer Institute Corp · R01 · FY2024 · HL
NEXT-GEN, OFF-THE-SHELF, CAR-NKT CELL THERAPY FOR METASTATIC CLEAR CELL RENAL CELL CARCINOMA.
$708,750University Of California, Los Angeles · · FY2024 · Defense Health Agency
Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin
$708,733Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · HL
Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin
$708,733Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · HL
Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin
$708,733Jesus Tejero Bravo · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · HL
NANOPHOTOSENSITIZERS FOR REGENERATIVE PHOTOTHERAPY
$708,514Samuel Achilefu · Washington University · R01 · FY2021 · CA
SaTC: CORE: Medium: Collaborative: Using Machine Learning to Build More Resilient and Transparent Computer Systems
$707,625Ljudevit Bauer · Carnegie Mellon University · · FY2018 · CSE
Diabetes Prevention for Hispanics Residing in Rural Communities: A Mobile Web-based Approach
$707,516Debra Rios · Isa Associates, Inc. · R44 · FY2022 · MD
S&AS: FND: Reliable Semi-Autonomy with Diminishing Reliance on Humans
$707,512Shlomo Zilberstein · University Of Massachusetts Amherst · · FY2017 · CSE
Neurocognitive and Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell Therapy: A Controlled Comparison
$707,291Heather S.l. Jim · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Montana Cancer Consortium NCORP
$706,794Benjamin T. Marchello · Montana Cancer Consortium · UG1 · FY2017 · CA
Away From Home and Out of School
$706,304Deborah A Cohen · Rand Corporation · R01 · FY2007 · HL
Urological and Renal Disease Engaging Adolescents in Adherence Collaborative Trial
$705,866Sandra Amaral · Children'S Hosp Of Philadelphia · R01 · FY2017 · DK
ANDROGEN METABOLISM IN CHILDHOOD
$705,730Maria I. New · Icahn School Of Medicine At Mount Sinai · R37 · FY2006 · HD
Outcomes for CLL patients treated with novel therapy
$705,542Neil E Kay · Mayo Clinic Rochester · R01 · FY2021 · CA
CORE C Technology Implementation/Development and Correlative Sciences
$705,526Friederike Herbst-Nowrouzi · University Of Pennsylvania · P01 · FY2025 · CA
Mobile Ecological Momentary Diet Assessment: A Low Burden, Ecologically-Valid Approach to Measuring Dietary Intake in Near-Real Time
$705,426Susan Schembre · University Of Arizona · R01 · FY2021 · CA
AI-Driven Digital Pathology Tool for Evaluating Inflammation and Therapeutic Efficacy in Preclinical Models
$705,182Maneesh Dave · University Of California At Davis · R01 · FY2025 · EB
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
$705,167Xiuli Wang · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Functional Genomics of Chemical -Induced Acute Lung Injury
$705,036George Douglas Leikauf · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · ES
Unified Intervention to Impact HIV Care Continuum
$704,924Seth C Kalichman · University Of Connecticut Storrs · R01 · FY2019 · DA
Leveraging fructose transport to create a privileged substrate to selectively fuel T cells
$704,431Kayvan R Keshari · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Brain-Imaging Markers of Neurotoxicity and Long-Term Outcomes after CAR-T Cell Therapy
$704,305Ravi Bansal · Children'S Hospital Of Los Angeles · R01 · FY2025 · CA
Enhanced persistence of CAR Tregs in the CNS for Alzheimerâs disease therapy
$704,198Charles L Sentman · Dartmouth College · R61 · FY2025 · AG